• MK-571: A Dual-Pathway Assay Strategy

  2026-08-14

  MK-571 (L-660,711) is more than a leukotriene D4 receptor antagonist: its ABCC1/MRP1 activity can materially shape macrophage chemotherapy assays. This guide explains how to separate receptor pharmacology from transporter-dependent redox protection in inflammation and drug-resistance research.

• Anti-ROR1 Antibody: Assay Design Beyond Binding

  2026-08-13

  Anti-ROR1 Antibody (Zilovertamab) can support a layered strategy that separates target binding, pathway modulation, and phenotype. This article also explains how mechanistic lessons from DON-induced liver injury improve causal assay design without implying that ROR1 mediates toxin hepatotoxicity.

• Dimethyloxalylglycine (DMOG) Protocol Guide

  2026-08-13

  Dimethyloxalylglycine (DMOG), SKU A4506, is a cell-permeable PHD inhibitor used for hypoxia-inducible factor stabilization in research models, with dossier-supported in vitro activity at 0.1–1 mmol/L. This guide covers solution handling, controls, QC, and interpretation for hypoxia signaling and inflammation and infection research; DMOG is not intended for clinical or diagnostic use.

• Caspase-4 Colorimetric Assay Kit Guide

  2026-08-12

  Learn how SKU K2199 supports quantitative, LEVD-dependent caspase-4 activity detection in pyroptosis, inflammation, and cell-death studies. This scenario-based guide covers assay selection, protocol controls, data interpretation, and practical limitations for reliable laboratory workflows.

• Protein A/G Magnetic Beads: Practical Workflow

  2026-08-12

  APExBIO K1305 Protein A/G Magnetic Beads support Fc-directed antibody capture for purification, immunoprecipitation, co-immunoprecipitation, and chromatin immunoprecipitation workflows. They are intended for research use with compatible IgG antibodies and should not be treated as diagnostic or medical products; antibody subclass, Fc accessibility, sample composition, and assay conditions require experimental verification.

• Epacadostat: Designing Context-Aware IDO1 Assays

  2026-08-11

  Epacadostat (INCB024360) is an oral IDO1 inhibitor for dissecting tryptophan metabolism and tumor-associated immune suppression. This guide presents a context-aware assay strategy that connects biochemical potency with whole-blood cytokine biology and translational immuno-oncology decisions.

• Phosphotungstic Acid Negative Stain Solution for Virology

  2026-08-11

  Conserved coronavirus glycans create a compelling translational target, but mechanism-driven virology also requires robust structural quality control. This thought-leadership guide explains how 2% phosphotungstic acid negative staining can support virus imaging, particle assessment, and decision-making without overstating what routine electron microscopy can prove.

• Acetylspiramycin: From Ribosome to Translation

  2026-08-10

  Acetylspiramycin, or Spiramycin B, is more than a macrolide reference compound. Its 50S-ribosome mechanism, activity against challenging bacterial models, and relevance to component-defined antibiotic production make it a strategic tool for antimicrobial resistance research and translational assay design.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody Workflow

  2026-08-09

  Build clearer immunofluorescence, flow cytometry, and tissue-imaging workflows with a fluorescein-conjugated secondary antibody designed for rabbit primary antibodies. This guide connects practical detection choices with the IL-11/GP130 fibrosis study while emphasizing controls, quantification, storage, and troubleshooting.

• PEDV Hijacks IMPDH-Dependent Nucleotide Biosynthesis

  2026-08-08

  The reference study identifies IMPDH-dependent guanine nucleotide biosynthesis as a host pathway that porcine epidemic diarrhea virus (PEDV) requires for efficient replication. By combining comparative metabolomics, IMPDH2 knockdown, and pharmacological inhibition with Merimepodib (VX-497), the authors provide evidence for a host-directed antiviral vulnerability while also revealing cell-specific metabolic responses.

• Inflammation in Ischemic Stroke: Biomarkers to Treatment

  2026-08-07

  Xiao and colleagues’ 2025 review integrates inflammatory mechanisms, biomarkers, and treatment research in ischemic stroke into a single translational framework. Its practical value lies in linking the timing and compartmentalization of inflammation with diagnostic interpretation and therapeutic design, while emphasizing that biomarker-guided treatment remains context dependent.

• DiD (DiDC 18 (5)): Advanced Membrane Probing in Inflammation

  2026-08-07

  Explore how DiD (DiDC 18 (5)) enables precise cell membrane staining and tracking in complex inflammatory and high-ROS environments. This article reveals unique protocol insights and cross-disciplinary applications, offering a deeper scientific perspective on this red fluorescent probe.

• Hydrocortisone in Precision Model Systems: Pathways and Prot

  2026-08-06

  Explore how hydrocortisone, a core glucocorticoid hormone, enables precision modeling of anti-inflammatory and stress response pathways. This article reveals advanced applications, mechanistic insights, and assay decision guidance not covered elsewhere.

• Berberrubine Modulates Urate Transport and JAK2/STAT3 in Hyp

  2026-08-06

  This study demonstrates that berberrubine, a major berberine metabolite, effectively lowers serum uric acid and ameliorates kidney injury in a murine hyperuricemia model. Through regulation of urate transporters and suppression of the JAK2/STAT3 pathway, berberrubine provides mechanistic insight into inflammation control and urate handling, with implications for metabolic disease research.

• PAD4-IN-2 TFA: Targeting NETs for Precision Tumor Research

  2026-08-05

  PAD4-IN-2 TFA (Compound 5i TFA) leverages meta-phenylboronic acid modification for tumor-selective inhibition of PAD4, enabling researchers to dissect and modulate the tumor immune microenvironment with minimal toxicity. This guide translates cutting-edge findings into actionable workflows, troubleshooting tips, and comparative insights for advanced cancer research using APExBIO’s PAD4-IN-2 TFA.

8436 records 11/563 page Previous Next First page 上5页 1112131415 下5页 Last page